电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

TRAF1 抗体 (AA 73-219)

This anti-TRAF1 antibody is a 小鼠 单克隆 antibody detecting TRAF1 in IHC 和 StM. Suitable for 人.
产品编号 ABIN6940806
发货至: 中国

Quick Overview for TRAF1 抗体 (AA 73-219) (ABIN6940806)

抗原

See all TRAF1 抗体
TRAF1 (TNF Receptor-Associated Factor 1 (TRAF1))

适用

  • 74
  • 34
  • 19
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1

宿主

  • 49
  • 28
  • 1
小鼠

克隆类型

  • 52
  • 26
单克隆

标记

  • 37
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TRAF1 antibody is un-conjugated

应用范围

  • 34
  • 31
  • 20
  • 19
  • 13
  • 13
  • 7
  • 5
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Staining Methods (StM)

克隆位点

TRAF1-3298
  • 抗原表位

    • 23
    • 15
    • 8
    • 6
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 73-219

    特异性

    This MAb recognizes a protein of 52 kDa, which is identified as TNFR1 (TNFR-associated factor 1). CD30-positive lymphoproliferations of the skin comprise 30 % of all primary cutaneous T-cell lymphomas (CTCLs). Besides borderline cases this group includes lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large T-cell lymphoma (cALCL). Although the two entities overlap clinically, histopathologically, immunopathologically and genetically, they differ considerably in their prognosis. In particular, common feature of both cases is histologically the presence of atypical lymphoid CD30-positive T blasts and genetically a clonal T-cell-receptor rearrangement. However, both cases differ considerably in their clinical course: Lesions of LyP regress spontaneously, whereas those of cALCL persist and may progress and spread. Moreover, LyP patients do not benefit from an aggressive radio- and/or chemotherapeutic approach, in contrast to patients with cALCL. Besides, LyP and cALCL differ strongly in the expression of TRAF1 (tumor necrosis factor receptor (TNFR)-associated factor 1), a component of TNFR signaling: Whereas tumor cells of most LyP cases (ca. 84 %) show a strong TRAF1 expression, tumor cells of cALCL reveal TRAF1 expression in only a few cases (ca. 7 %). Antibody to TRAF1 is highly useful for the differentiation of LyP and cALCL in patients with cutaneous CD30-positive lymphoproliferations.

    纯化方法

    Purified by Protein A/G

    免疫原

    Recombinant fragment of human TRAF1 protein (around aa 73-219) (exact sequence is proprietary)

    亚型

    IgG2b kappa
  • 应用备注

    Positive Control: HeLa or 293T cells. Hodgkin s Lymphoma (IHC).

    Known Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT) ,(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    限制

    仅限研究用
  • 浓度

    200 μg/mL

    缓冲液

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    4 °C,-80 °C

    储存方法

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    有效期

    24 months
  • 抗原

    TRAF1 (TNF Receptor-Associated Factor 1 (TRAF1))

    别名

    TRAF1

    分子量

    52kDa

    基因ID

    7185

    UniProt

    Q13077

    途径

    NF-kappaB Signaling, Apoptosis, Cell-Cell Junction Organization, Asymmetric Protein Localization
You are here:
Chat with us!